在使用 EMiC2 过滤器进行肾脏替代治疗时,清除脓毒症急性肾损伤患者的炎症细胞因子(Clic-AKI 研究)。
Clearance of inflammatory cytokines in patients with septic acute kidney injury during renal replacement therapy using the EMiC2 filter (Clic-AKI study).
机构信息
Department of Critical Care, Guy's and St Thomas' Hospital, King's College London, NHS Foundation Trust, 249 Westminster Bridge Road, London, SE1 7EH, UK.
Division of Nephrology and Excellence Centre for Critical Care Nephrology, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
出版信息
Crit Care. 2021 Jan 28;25(1):39. doi: 10.1186/s13054-021-03476-x.
BACKGROUND
The EMiC2 membrane is a medium cut-off haemofilter (45 kiloDalton). Little is known regarding its efficacy in eliminating medium-sized cytokines in sepsis. This study aimed to explore the effects of continuous veno-venous haemodialysis (CVVHD) using the EMiC2 filter on cytokine clearance.
METHODS
This was a prospective observational study conducted in critically ill patients with sepsis and acute kidney injury requiring kidney replacement therapy. We measured concentrations of 12 cytokines [Interleukin (IL) IL-1β, IL-1α, IL-2, IL-4, IL-6, IL-8, IL-10, interferon (IFN)-γ, tumour necrosis factor (TNF)-α, vascular endothelial growth factor, monocyte chemoattractant protein (MCP)-1, epidermal growth factor (EGF)] in plasma at baseline (T0) and pre- and post-dialyzer at 1, 6, 24, and 48 h after CVVHD initiation and in the effluent fluid at corresponding time points. Outcomes were the effluent and adsorptive clearance rates, mass balances, and changes in serial serum concentrations.
RESULTS
Twelve patients were included in the final analysis. All cytokines except EGF concentrations declined over 48 h (p < 0.001). The effluent clearance rates were variable and ranged from negligible values for IL-2, IFN-γ, IL-1α, IL-1β, and EGF, to 19.0 ml/min for TNF-α. Negative or minimal adsorption was observed. The effluent and adsorptive clearance rates remained steady over time. The percentage of cytokine removal was low for most cytokines throughout the 48-h period.
CONCLUSION
EMiC2-CVVHD achieved modest removal of most cytokines and demonstrated small to no adsorptive capacity despite a decline in plasma cytokine concentrations. This suggests that changes in plasma cytokine concentrations may not be solely influenced by extracorporeal removal.
TRIAL REGISTRATION
NCT03231748, registered on 27th July 2017.
背景
EMiC2 膜是一种中值截止的血液滤过器(45 千道尔顿)。对于其在脓毒症中消除中分子量细胞因子的功效知之甚少。本研究旨在探讨使用 EMiC2 过滤器进行连续静脉-静脉血液透析(CVVHD)对细胞因子清除的影响。
方法
这是一项在需要肾脏替代治疗的脓毒症和急性肾损伤的危重病患者中进行的前瞻性观察研究。我们测量了血浆中 12 种细胞因子[白细胞介素(IL)IL-1β、IL-1α、IL-2、IL-4、IL-6、IL-8、IL-10、干扰素(IFN)-γ、肿瘤坏死因子(TNF)-α、血管内皮生长因子、单核细胞趋化蛋白(MCP)-1、表皮生长因子(EGF)]的浓度,在 CVVHD 开始前(T0)、1、6、24 和 48 小时后在预滤器和后滤器以及相应时间点在流出液中的浓度。结果是流出液和吸附清除率、质量平衡以及连续血清浓度的变化。
结果
最终分析包括 12 名患者。除 EGF 浓度外,所有细胞因子在 48 小时内均下降(p<0.001)。流出液清除率各不相同,范围从 IL-2、IFN-γ、IL-1α、IL-1β 和 EGF 的可忽略值到 TNF-α的 19.0ml/min。观察到阴性或最小吸附。流出液和吸附清除率随时间保持稳定。在整个 48 小时期间,大多数细胞因子的细胞因子去除率都很低。
结论
尽管血浆细胞因子浓度下降,但 EMiC2-CVVHD 对大多数细胞因子的清除效果中等,且吸附能力较小或没有。这表明,血浆细胞因子浓度的变化可能不仅仅受体外清除的影响。
试验注册
NCT03231748,于 2017 年 7 月 27 日注册。